Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19442535rdf:typepubmed:Citationlld:pubmed
pubmed-article:19442535lifeskim:mentionsumls-concept:C0238033lld:lifeskim
pubmed-article:19442535lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19442535lifeskim:mentionsumls-concept:C0015219lld:lifeskim
pubmed-article:19442535lifeskim:mentionsumls-concept:C1514474lld:lifeskim
pubmed-article:19442535lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:19442535lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:19442535pubmed:issue3lld:pubmed
pubmed-article:19442535pubmed:dateCreated2010-2-1lld:pubmed
pubmed-article:19442535pubmed:abstractTextInfiltrating MBC represents less than 1% of all male cancers. Our study details clinico-pathological features, treatments and prognostic factors in a large French cohort.lld:pubmed
pubmed-article:19442535pubmed:languageenglld:pubmed
pubmed-article:19442535pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19442535pubmed:citationSubsetIMlld:pubmed
pubmed-article:19442535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19442535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19442535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19442535pubmed:statusMEDLINElld:pubmed
pubmed-article:19442535pubmed:monthMarlld:pubmed
pubmed-article:19442535pubmed:issn1879-0461lld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:MignotteHHlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:SerioGGlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:GadaMMlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:CutuliBBlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:RomestaingPPlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:De LafontanBBlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:MaingonPPlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:CometBBlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:Penault-Llorc...lld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:BelkacemiYYlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:KirovaYYlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:LemanskiCClld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:ZoubirMMlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:de LaraC...lld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:EdelineJJlld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:Le-NirC...lld:pubmed
pubmed-article:19442535pubmed:authorpubmed-author:DelvaCClld:pubmed
pubmed-article:19442535pubmed:copyrightInfoCopyright 2009 Elsevier Ireland Ltd. All rights reserved.lld:pubmed
pubmed-article:19442535pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19442535pubmed:volume73lld:pubmed
pubmed-article:19442535pubmed:ownerNLMlld:pubmed
pubmed-article:19442535pubmed:authorsCompleteYlld:pubmed
pubmed-article:19442535pubmed:pagination246-54lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:meshHeadingpubmed-meshheading:19442535...lld:pubmed
pubmed-article:19442535pubmed:year2010lld:pubmed
pubmed-article:19442535pubmed:articleTitleMale breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.lld:pubmed
pubmed-article:19442535pubmed:affiliationRadiation Oncology Department, Polyclinique de Courlancy, 38 rue de Courlancy, 51100 Reims, France. bcutuli@oncorad.courlancy.frlld:pubmed
pubmed-article:19442535pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19442535pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed